 Immunohistochemical staining CA antigen human bladder cancer Relation grade clinical stage prognosis immunohistochemical detection tumor marker CA bladder cancer WHO I-III material tumors patients mean clinical follow-up time thirteen years years fraction CA cells FPtot microscopic image percent staining region fraction CA cells region percent FPmax average staining intensity CA cells whole section ASItot staining area ASImax inverse relation histologic grade FPtot ASItot significant FPtot ASItot clinical stage Occurrence metastasis follow-up low CA positivity FPtot ASItot staining intensity fraction CA cells aggressive tumor survival analysis low FPtot ASItot values high risk bladder cancer death results immunohistochemical staining bladder tumor CA bladder cancer aggressiveness survival